SPAC Tax Treatment

Treatment of Tax Attributes for Special Purpose Acquisition Companies

Special Purpose Acquisition Companies (SPACs) are publicly traded companies formed for the sole purpose of raising capital through an IPO and using the proceeds to acquire one or more unspecified businesses in the future. The management team that forms the SPAC (the “sponsor”) forms the entity and funds the offering expenses in exchange for founder shares. There are various tax considerations and complexities that can have significant implications both during the SPAC  formation process and down the road.

When an IPO results in an “ownership change” – as is the case with a SPAC transaction – net operating losses (NOLs) could be impaired based on Internal Revenue Code rules that are designed to discourage the acquisition of loss-making companies in order to utilize NOLs. An ownership change occurs when one or more shareholders increase their ownership of the stock (measured by value) of the NOL company by more than 50 percentage points compared to the lowest ownership percentage during a lookback testing period (normally three years). In such a case, a company with NOLs will often be allowed to use only a fraction of those NOLs to offset income in future years.

Under pre-CARES Act law, Section 172(a) of the Internal Revenue Code provided that the amount of an NOL deduction was equal to the lesser of the aggregate of NOL carryovers and NOL carrybacks to such year, or 80% of taxable income without regard to the NOL deduction (for NOLs arising in post-2017 taxable years). Thus, such NOLs were subject to a taxable-income limitation and could not fully offset income. The 80% limitation did not apply to NOLs arising in pre-2018 taxable years.

The CARES Act temporarily removes the 80% taxable-income limitation to allow an NOL carryforward to fully offset income. For taxable years beginning before 2021, taxpayers can take an NOL deduction equal to 100% of taxable income.

Also, for taxable years beginning in 2021 and thereafter, taxpayers will be able to take a 100% deduction for NOLs arising in taxable years beginning before 2018, and a deduction limited to 80% of modified taxable income for NOLs arising in taxable years beginning after 2017.

MFA Observations
Affected parties should plan well in advance of an IPO to take into account the potential limitation of the use of any NOLs post-IPO. Connect with a member of MFA’s Tax Team today to effectively plan for such cases.

Contact Us

SPAC Resource Center

Related posts
biotech ipo list

Biotech IPO Checklist: Compliance Readiness & Leadership

In the push to innovate patient care and improve health outcomes, biotech IPOs are on…

Read More
SPACs Tax Treatment Startup Expenses

Tax Treatment of Transaction Costs and Startup Expenses for SPACs

Creating a SPAC is not without expense. Some expenses are incurred pre-IPO, some will be…

Read More